日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Individual Pharmacotherapy Management (IPM-II) for Patient and Drug Safety in Polypharmacy via Clinical Electronic Health Record Is Associated with Significant Fall Prevention

通过临床电子健康记录进行个体化药物治疗管理（IPM-II）以保障多重用药患者和药物安全，可显著降低跌倒风险

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph17121587
Wolf, Ursula; Drewas, Luise; Ghadir, Hassan; Bauer, Christian; Becherer, Lars; Delank, Karl-Stefan; Neef, Rüdiger
发表日期：2024
文献求助 收藏

Underdiagnosed CKD in Geriatric Trauma Patients and Potent Prevention of Renal Impairment from Polypharmacy Risks through Individual Pharmacotherapy Management (IPM-III)

老年创伤患者慢性肾病诊断不足及通过个体化药物治疗管理（IPM-III）有效预防多重用药风险导致的肾功能损害

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm12134545
Wolf, Ursula; Ghadir, Hassan; Drewas, Luise; Neef, Rüdiger
发表日期：2023
文献求助 收藏

Individual Pharmacotherapy Management (IPM) - I: a group-matched retrospective controlled clinical study on prevention of complicating delirium in the elderly trauma patients and identification of associated factors

个体化药物治疗管理（IPM）- I：一项针对老年创伤患者预防并发谵妄及识别相关因素的组匹配回顾性对照临床研究

期刊:BMC Geriatrics
影响因子:3.8
doi:10.1186/s12877-021-02630-y
Drewas, Luise; Ghadir, Hassan; Neef, Rüdiger; Delank, Karl-Stefan; Wolf, Ursula
发表日期：2022
文献求助 收藏